Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade and had a positive
result on government deficit. The investment law approved recently has good statements and rules on the above strategy
particularly to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical
changes in the pharmacy regulations to improve the effectiveness of the public pharmacy i.e., resources should be switched
towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through
cost sharing or full private. The role of the private services is significant. A review and reform of financing medicines in Sudan
is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsible for
the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or
quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against
counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated
to ensure the public health and is protected against by marketing high quality medicines rather than commercial interests and
the drug companies are held accountable for their conducts.